Anaconda Biomed Names Dr. Charles Carignan Board Chairman
Company - People | Jun 11, 2025 | Ysios Capital
Anaconda Biomed, a medical technology company developing next-generation thrombectomy systems for ischemic stroke treatment, has appointed Dr. Charles Carignan as the new chairman of its board of directors. With a robust background in clinical, product development, and leadership at numerous prestigious institutions and corporations, Dr. Carignan brings a wealth of expertise to Anaconda Biomed. He has previously held significant roles, such as the founding president and CEO of NinePoint Medical, CEO of SoniVie Inc., and chief medical officer at Boston Scientific's Endosurgery. Dr. Carignan's appointment comes at a strategic time as Anaconda Biomed is advancing through its ATHENA clinical trial and expanding its product pipeline. His experience is expected to be instrumental in guiding the company through this growth phase. The company’s innovative ANA Funnel Catheter, designed for neurovascular procedures, exemplifies the cutting-edge technology under development at Anaconda Biomed. Although still under investigation, the device shows promise for shaping the future of mechanical thrombectomy treatments.
Sectors
- Medical Technology
- Biotechnology
Geography
- Spain – Anaconda Biomed is based in Barcelona, Spain, which serves as a geographical focus in the article.
- United States – The discussion of Dr. Carignan's extensive career and the references to U.S. institutions and potential markets highlight the United States as another key geography.
Industry
- Medical Technology – The article focuses on Anaconda Biomed's development of thrombectomy systems, which falls under the medical technology industry.
- Biotechnology – The focus on innovative stroke treatment and product pipeline places Anaconda Biomed in the biotechnology sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Anaconda Biomed S.L. | Target Company | Company | A medical technology company focused on developing thrombectomy systems for stroke treatment. |
| Dr. Charles Carignan | Chairman of the Board | Person | Newly appointed chairman with extensive experience in medtech leadership and product development. |
| Ysios Capital | Investor | Company | A private equity firm backing Anaconda Biomed, focused on life sciences investment. |
| ANA Funnel Catheter | Product | Other | An investigational device aimed at neurovascular procedures, central to Anaconda Biomed's innovation pipeline. |